Mesothelioma Clinical Trial Results May Be Skewed by Narrow Inclusion Criteria
| | | |

Mesothelioma Clinical Trial Results May Be Skewed by Narrow Inclusion Criteria

Australian researchers say too many mesothelioma clinical trial results are skewed because they do not include enough “real world” patients.   By “real world patients”, they mean those who fit the profile of the typical mesothelioma patient. The researchers say some of the most important trials limit enrollment to younger people or those with few other health problems.  They say that leaves out a lot of patients. It also makes mesothelioma clinical trial results less relevant in practice.  How Clinical Trials Work Scientists typically test proposed new mesothelioma treatments on isolated cells in a lab first. If the results look promising, they will then run tests in animals to make sure the treatment is safe.   Before a medicine receives approval for…